NL7304699A - - Google Patents

Info

Publication number
NL7304699A
NL7304699A NL7304699A NL7304699A NL7304699A NL 7304699 A NL7304699 A NL 7304699A NL 7304699 A NL7304699 A NL 7304699A NL 7304699 A NL7304699 A NL 7304699A NL 7304699 A NL7304699 A NL 7304699A
Authority
NL
Netherlands
Application number
NL7304699A
Other versions
NL172402B (nl
NL172402C (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7304699A publication Critical patent/NL7304699A/xx
Priority to NLAANVRAGE8300208,A priority Critical patent/NL183012C/xx
Publication of NL172402B publication Critical patent/NL172402B/xx
Application granted granted Critical
Publication of NL172402C publication Critical patent/NL172402C/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NLAANVRAGE7304699,A 1972-04-05 1973-04-04 Werkwijze voor het bereiden van een dermatologisch preparaat. NL172402C (nl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NLAANVRAGE8300208,A NL183012C (nl) 1972-04-05 1983-01-20 Anti-acnepreparaat.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24140472A 1972-04-05 1972-04-05

Publications (3)

Publication Number Publication Date
NL7304699A true NL7304699A (US06168776-20010102-C00028.png) 1973-10-09
NL172402B NL172402B (nl) 1983-04-05
NL172402C NL172402C (nl) 1983-09-01

Family

ID=22910564

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7304699,A NL172402C (nl) 1972-04-05 1973-04-04 Werkwijze voor het bereiden van een dermatologisch preparaat.

Country Status (15)

Country Link
JP (1) JPS5331222B2 (US06168776-20010102-C00028.png)
AT (1) AT352283B (US06168776-20010102-C00028.png)
BE (1) BE797763A (US06168776-20010102-C00028.png)
CH (1) CH593690A5 (US06168776-20010102-C00028.png)
DE (2) DE2316597C3 (US06168776-20010102-C00028.png)
DK (1) DK138929B (US06168776-20010102-C00028.png)
FI (1) FI52427C (US06168776-20010102-C00028.png)
FR (1) FR2182935B1 (US06168776-20010102-C00028.png)
GB (1) GB1400643A (US06168776-20010102-C00028.png)
IE (1) IE37447B1 (US06168776-20010102-C00028.png)
NL (1) NL172402C (US06168776-20010102-C00028.png)
NO (1) NO141740C (US06168776-20010102-C00028.png)
PH (1) PH15138A (US06168776-20010102-C00028.png)
SE (1) SE419940B (US06168776-20010102-C00028.png)
ZA (1) ZA732269B (US06168776-20010102-C00028.png)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2383667A1 (fr) * 1977-03-16 1978-10-13 Desjonqueres Stephane Medicament contre l'acne
JPS5668603A (en) * 1979-11-09 1981-06-09 Nippon Saafuakutanto Kogyo Kk Cosmetic
JPS60116218U (ja) * 1984-01-17 1985-08-06 東北金属工業株式会社 チヨ−クコイル
LU85643A1 (fr) * 1984-11-16 1986-06-04 Oreal Composition cosmetique thermo-amincissante a base d'extraits vegetaux oleosolubles
GB8514975D0 (en) * 1985-06-13 1985-07-17 Sempernova Plc Compositions
US4865848A (en) * 1987-02-26 1989-09-12 Alza Corporation Skin permeation enhancer compositions using sucrose esters
IL97075A0 (en) * 1990-02-14 1992-03-29 Alcon Lab Inc Topical pharmaceutical composition containing an alkyl saccharide
AU633207B2 (en) * 1990-03-30 1993-01-21 Alza Corporation Compositions comprising cytotoxic agent and permeation enhancers
JPH0817647A (ja) * 1994-06-24 1996-01-19 I Kiyuu For:Kk トランス
US6017549A (en) * 1997-09-30 2000-01-25 E-L Management Corp. Non-irritating cosmetic and pharmaceutical compositions
AUPQ291499A0 (en) * 1999-09-17 1999-10-07 Women's And Children's Hospital Adelaide Novel nitro and sulphur containing compounds
CA3070246A1 (en) 2017-07-20 2019-01-24 Thomas Leibbrand Tyrothricin for use in the treatment or prophylaxis of body odour and preparations therefor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE644613A (US06168776-20010102-C00028.png) * 1963-12-09 1964-07-01
DE1620109A1 (de) * 1964-06-29 1970-03-05 Procter & Gamble Antischweissmittel
US3527864A (en) * 1966-11-18 1970-09-08 Procter & Gamble Compositions for topical application to animal tissue and method of enhancing penetration thereof

Also Published As

Publication number Publication date
DK138929B (da) 1978-11-20
FR2182935B1 (US06168776-20010102-C00028.png) 1976-12-31
IE37447B1 (en) 1977-07-20
NL172402B (nl) 1983-04-05
IE37447L (en) 1973-10-05
DE2316597B2 (de) 1978-03-16
PH15138A (en) 1982-08-24
JPS5331222B2 (US06168776-20010102-C00028.png) 1978-09-01
NL172402C (nl) 1983-09-01
BE797763A (fr) 1973-10-04
DE2366081A1 (de) 1977-10-06
DE2316597A1 (de) 1973-10-18
NO141740C (no) 1980-05-07
FI52427C (fi) 1977-09-12
DE2316597C3 (de) 1978-11-02
CH593690A5 (US06168776-20010102-C00028.png) 1977-12-15
ZA732269B (en) 1974-01-30
AT352283B (de) 1979-09-10
ATA295673A (de) 1979-02-15
NO141740B (no) 1980-01-28
JPS4925113A (US06168776-20010102-C00028.png) 1974-03-06
SE419940B (sv) 1981-09-07
FI52427B (US06168776-20010102-C00028.png) 1977-05-31
GB1400643A (en) 1975-07-23
FR2182935A1 (US06168776-20010102-C00028.png) 1973-12-14
DE2366081C2 (de) 1985-11-07
DK138929C (US06168776-20010102-C00028.png) 1979-05-07

Similar Documents

Publication Publication Date Title
JPS5527220B2 (US06168776-20010102-C00028.png)
FR2182935B1 (US06168776-20010102-C00028.png)
JPS5226225B2 (US06168776-20010102-C00028.png)
JPS48103786A (US06168776-20010102-C00028.png)
JPS5130620B2 (US06168776-20010102-C00028.png)
JPS491946A (US06168776-20010102-C00028.png)
JPS4918510U (US06168776-20010102-C00028.png)
JPS4969376U (US06168776-20010102-C00028.png)
FR2178727A1 (US06168776-20010102-C00028.png)
JPS5213515Y2 (US06168776-20010102-C00028.png)
JPS5224560Y2 (US06168776-20010102-C00028.png)
FR2194333A5 (US06168776-20010102-C00028.png)
JPS571985Y2 (US06168776-20010102-C00028.png)
CS159097B1 (US06168776-20010102-C00028.png)
JPS4993105U (US06168776-20010102-C00028.png)
JPS4916590U (US06168776-20010102-C00028.png)
JPS4922334U (US06168776-20010102-C00028.png)
JPS4990803U (US06168776-20010102-C00028.png)
BG21231A3 (US06168776-20010102-C00028.png)
CH571376A5 (US06168776-20010102-C00028.png)
BG18348A1 (US06168776-20010102-C00028.png)
BG20298A3 (US06168776-20010102-C00028.png)
BG18093A1 (US06168776-20010102-C00028.png)
BG20556A3 (US06168776-20010102-C00028.png)
BG18040A1 (US06168776-20010102-C00028.png)

Legal Events

Date Code Title Description
V4 Lapsed because of reaching the maximum lifetime of a patent